Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-07-001747
Filing Date
2007-03-01
Accepted
2007-02-28 21:52:35
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. - FORM 10-K g05196e10vk.htm 10-K 2025543
2 EX-21.1 SUBISDIARIES OF THE REGISTRANT g05196exv21w1.htm EX-21.1 4752
3 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP g05196exv23w1.htm EX-23.1 2382
4 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g05196exv31w1.htm EX-31.1 9295
5 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g05196exv31w2.htm EX-31.2 9287
6 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g05196exv32w1.htm EX-32.1 3870
7 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO g05196exv32w2.htm EX-32.2 3862
8 GRAPHIC g05196g0519601.gif GRAPHIC 9515
  Complete submission text file 0000950144-07-001747.txt   2073619
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 07660320
SIC: 2834 Pharmaceutical Preparations